UA90013C2 - Фармацевтическая композиция, содержащая инсулин, и способ его получения - Google Patents

Фармацевтическая композиция, содержащая инсулин, и способ его получения

Info

Publication number
UA90013C2
UA90013C2 UAA200803496A UAA200803496A UA90013C2 UA 90013 C2 UA90013 C2 UA 90013C2 UA A200803496 A UAA200803496 A UA A200803496A UA A200803496 A UAA200803496 A UA A200803496A UA 90013 C2 UA90013 C2 UA 90013C2
Authority
UA
Ukraine
Prior art keywords
preparation
pharmaceutical composition
composition containing
containing insulin
insulin
Prior art date
Application number
UAA200803496A
Other languages
English (en)
Ukrainian (uk)
Inventor
Давид Анатолійович Нога
Павло Георгійович Матвєєв
Сєргєй Сєргєєвіч Маркін
Дмітрій Борісовіч Бєрєнштейн
Міхаіл Пєтровіч Сємьонов
Олександр Андрійович Тарасов
Ольга Маратовна ТАРАСОВА
Ігор В'ячеславович Рєдькін
Original Assignee
Давид Анатолійович Нога
Павло Георгійович Матвєєв
Сєргєй Сєргєєвіч Маркін
Дмітрій Борісовіч Бєрєнштейн
Міхаіл Пєтровіч Сємьонов
Олександр Андрійович Тарасов
Ольга Маратовна ТАРАСОВА
Ігор В'ячеславович Рєдькін
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Давид Анатолійович Нога, Павло Георгійович Матвєєв, Сєргєй Сєргєєвіч Маркін, Дмітрій Борісовіч Бєрєнштейн, Міхаіл Пєтровіч Сємьонов, Олександр Андрійович Тарасов, Ольга Маратовна ТАРАСОВА, Ігор В'ячеславович Рєдькін filed Critical Давид Анатолійович Нога
Priority to UAA200803496A priority Critical patent/UA90013C2/ru
Priority to CA2718915A priority patent/CA2718915A1/en
Priority to PCT/UA2008/000019 priority patent/WO2009116960A1/ru
Priority to DK08767349.7T priority patent/DK2266596T3/da
Priority to EP08767349.7A priority patent/EP2266596B1/en
Publication of UA90013C2 publication Critical patent/UA90013C2/ru
Priority to US12/883,984 priority patent/US20110064818A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к области получения лекарственных средств для лечения диабета и касается способа получения фармацевтической композиции, содержащей инсулин на полисахаридном носителе, который включает смешивание положительно заряженного золя хитозана с рН, равным 3,5-4,5 и отрицательно заряженного инсулина, который не содержит цинка, взят в виде коллоидного раствора или в виде наноразмерных кристаллических частичек. PН смешанного золя доводят до 5,5-6,5, проводят гелирование и обезвоживание геля с получением твердых частичек размером 10-100 мкм.
UAA200803496A 2008-03-19 2008-03-19 Фармацевтическая композиция, содержащая инсулин, и способ его получения UA90013C2 (ru)

Priority Applications (6)

Application Number Priority Date Filing Date Title
UAA200803496A UA90013C2 (ru) 2008-03-19 2008-03-19 Фармацевтическая композиция, содержащая инсулин, и способ его получения
CA2718915A CA2718915A1 (en) 2008-03-19 2008-03-25 Pharmaceutical composition and a method for the production thereof
PCT/UA2008/000019 WO2009116960A1 (ru) 2008-03-19 2008-03-25 Фармацевтическая композиция и способ её получения
DK08767349.7T DK2266596T3 (da) 2008-03-19 2008-03-25 Farmaceutisk sammensætning og fremgangsmåde til fremstilling deraf
EP08767349.7A EP2266596B1 (en) 2008-03-19 2008-03-25 Pharmaceutical composition and a method for the production thereof
US12/883,984 US20110064818A1 (en) 2008-03-19 2010-09-16 Pharmaceutical composition and a method for the production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA200803496A UA90013C2 (ru) 2008-03-19 2008-03-19 Фармацевтическая композиция, содержащая инсулин, и способ его получения

Publications (1)

Publication Number Publication Date
UA90013C2 true UA90013C2 (ru) 2010-03-25

Family

ID=41091167

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200803496A UA90013C2 (ru) 2008-03-19 2008-03-19 Фармацевтическая композиция, содержащая инсулин, и способ его получения

Country Status (6)

Country Link
US (1) US20110064818A1 (ru)
EP (1) EP2266596B1 (ru)
CA (1) CA2718915A1 (ru)
DK (1) DK2266596T3 (ru)
UA (1) UA90013C2 (ru)
WO (1) WO2009116960A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013164380A1 (en) * 2012-05-03 2013-11-07 Janssen R&D Ireland Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554388A (en) 1989-02-25 1996-09-10 Danbiosyst Uk Limited Systemic drug delivery compositions comprising a polycationi substance
RU2175556C2 (ru) 1994-03-07 2001-11-10 Инхейл Терапьютик Системз Способы и композиции для легочной доставки инсулина
RU2066551C1 (ru) * 1994-03-23 1996-09-20 Институт нефтехимического синтеза РАН Способ получения инсулинсодержащих полимерных гидрогелей
WO1996009814A1 (en) * 1994-09-29 1996-04-04 Andaris Limited Spray-dried microparticles as therapeutic vehicles
US6201072B1 (en) 1997-10-03 2001-03-13 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
UA24452C2 (ru) 1998-01-09 2003-08-15 Закритоє Акціонєрноє Общество "Фосфосорб" Рекомбинантная плазмидная днк, кодирующая препроинсулин человека и штамм escherichia coli xl1 - blue / p insr- продуцент препроинсулина
RU2148642C1 (ru) 1998-12-23 2000-05-10 ЗАО "Научно-исследовательский институт АДЖИНОМОТО-Генетика" (ЗАО "АГРИ") Фрагмент днк rhtc, кодирующий синтез белка rhtc, придающего повышенную устойчивость к l-треонину бактериям escherichia coli, и способ получения l-аминокислоты
DE19940794A1 (de) 1999-08-27 2001-03-01 Lohmann Therapie Syst Lts Pharmazeutische Zubereitung
EP1341522B1 (de) 2000-12-13 2005-11-16 Merckle Gmbh Mikropartikel mit verbessertem freisetzungsprofil und verfahren zu deren herstellung
CN100341567C (zh) 2001-07-05 2007-10-10 产业化研究株式会社 胰岛素的经鼻给药用组合物
FI116625B (fi) * 2004-01-28 2006-01-13 Macrocrystal Oy Menetelmä proteiinien kiteyttämiseksi hiilihydraattirunkoisilla polymeereillä
ES2277743B2 (es) * 2005-06-02 2008-12-16 Universidade De Santiago De Compostela Nanoparticulas que comprenden quitosano y ciclodextrina.
WO2008028264A1 (en) * 2006-09-05 2008-03-13 Centro Brasileiro De Pesquisas Fisicas-Cbpf Process for the production of micro-capsules having magnetic properties, product obtained therefrom and method for the controlled release of active substances
RU2316339C1 (ru) 2006-09-13 2008-02-10 Общество С Ограниченной Ответственностью "Концерн О3" Способ получения препарата инсулина для перорального применения

Also Published As

Publication number Publication date
WO2009116960A1 (ru) 2009-09-24
EP2266596B1 (en) 2014-07-02
US20110064818A1 (en) 2011-03-17
CA2718915A1 (en) 2009-09-24
EP2266596A1 (en) 2010-12-29
DK2266596T3 (da) 2014-10-13
EP2266596A4 (en) 2013-06-05

Similar Documents

Publication Publication Date Title
Fakhrullin et al. Hybrid cellular− inorganic core− shell microparticles: Encapsulation of individual living cells in calcium carbonate microshells
PH12015501782A1 (en) Method for production of commercial nanoparticles and microparticle powders
Zhang et al. Antimicrobial properties of metal nanoparticles and their oxide materials and their applications in oral biology
PH12015501780A1 (en) Production of encapsulated nanoparticles at commercial scale
UA88508C2 (ru) Региоселективно замещенный сульфат целлюлозы, его применение и способ получения, микрокапсулы, их применение и способ изготовления
EA201171279A1 (ru) Производство инкапсулированных наночастиц с высокой объемной долей
WO2011005381A3 (en) Vortex-induced silk fibroin gelation for encapsulation and delivery
EP2384740A3 (en) Oral care product and methods of use and manufacture thereof
WO2008103409A3 (en) Compositions of chloroquine coupled to antibodies and to other proteins with methods for their synthesis
BR0309894A (pt) Composição, processo para preparar uma composição de celulose microcristalina, produto alimentìcio, composição farmacêutica, composição cosmética, forma de dosagem farmacêutica, e, composição industrial
NZ596876A (en) Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
NZ595987A (en) A novel formulation of diclofenac
WO2007082155A3 (en) Molecules with complexing groups for aqueous nanoparticle dispersions and uses thereof
TW200711719A (en) Use of 2,3-dihydroxynaphthalene-6-sulfonic acid salts as dispersants
FR2935380B1 (fr) Nouveaux composes hexafluoro-2-biphenyl-isopropanol, modulateurs des recepteurs de type lxrs, leur procede de preparation et leur application comme medicaments en medecine humaine ou veterinaire ainsi qu'en cosmetique.
CN100569835C (zh) 一种羟丙基壳聚糖纳米微粒的制备方法
WO2010022031A8 (en) Topical hydrogel composition
UA90013C2 (ru) Фармацевтическая композиция, содержащая инсулин, и способ его получения
WO2011111067A3 (en) A biodegradable polymeric hydrogel composition
Homaeigohar et al. Biosynthesis of zinc oxide nanoparticles on l-carnosine biofunctionalized polyacrylonitrile nanofibers; a biomimetic wound healing material
CN104371021A (zh) 一种七肽复合水凝胶微球的制备方法
MD20140110A2 (ru) Лекарственное средство для лечения мастита у крупного рогатого скота и способ его получения
Jafari et al. Fabrication of BioMIL-4/Chitosan/Alginate-Based Nanocomposite Scaffolds for Bone Tissue Engineering
Nurdin et al. Synthesis and characterization of silica microcapsules with active compounds 2% chlorhexidine using sodium alginate and chitosan coating as medicament of root canal infection
CN102727491A (zh) 一种酸式阿莫西林及其生产方法